Metzger Michael A Insider Trades

Insider Trading History

Track insider trading activity for Metzger Michael A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Executive Officer
Holding Value $8.74M 484,843 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$130k 6,847 shares
$18.99
$18.02
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $78.4k 45,867 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 45,867 shares
$1.36
$1.71
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Executive Officer
Holding Value $8.86M 491,690 shares
Last Trade
Feb 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$361k 17,159 shares
$21.03
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Executive Officer
Holding Value $9.17M 508,849 shares
Last Trade
Feb 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$153k 7,412 shares
$20.62
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Executive Officer
Holding Value $9.3M 516,261 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.5M 657,600 shares
$20.48
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Executive Officer
Holding Value $5.38M 298,661 shares
Last Trade
Sep 08, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.58M 157,307 shares
$16.41
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Executive Officer
Holding Value $8.22M 455,968 shares
Last Trade
Sep 08, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.57M 157,307 shares
$16.33
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Executive Officer
Holding Value $5.38M 298,661 shares
Last Trade
Jul 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$70k 7,534 shares
$9.29
$18.02
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $63.2k 36,979 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.2k 36,979 shares
$0.98
$1.71
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Executive Officer
Holding Value $5.52M 306,195 shares
Last Trade
Mar 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$78.7k 6,074 shares
$12.95
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Executive Officer
Holding Value $5.41M 300,121 shares
Last Trade
Mar 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$118k 7,814 shares
$15.05
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Executive Officer
Holding Value $5.55M 307,935 shares
Last Trade
Mar 04, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$112k 7,814 shares
$14.38
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Executive Officer
Holding Value $5.41M 300,121 shares
Last Trade
Feb 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$206k 13,288 shares
$15.50
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Executive Officer
Holding Value $6.56M 364,000 shares
Last Trade
Feb 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.33M 364,000 shares
$14.65
$18.02
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $121k 70,683 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$281k 70,683 shares
$3.97
$1.71
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Executive Officer
Holding Value $3.87M 214,500 shares
Last Trade
Feb 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.78M 214,500 shares
$22.28
$18.02
CTI BioPharma
CTI BioPharma CTIC
Director
Holding Value $0 0 shares
Last Trade
Jun 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.76M 413,000 shares
$9.10
$9.10
CTI BioPharma
CTI BioPharma CTIC
Director
Holding Value $728k 80,000 shares
Last Trade
Apr 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$326k 80,000 shares
$4.08
$9.10
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Holding Value $426k 23,618 shares
Last Trade
Feb 06, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$158k 5,959 shares
$26.53
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Holding Value $318k 17,659 shares
Last Trade
Feb 06, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$165k 5,959 shares
$27.64
$18.02

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up